We developed the National Institutes of Health helping to end addiction long-term initiative morphine milligram equivalent (MME) calculator to standardize MME calculations across pain research studies, addressing a critical barrier to effective research synthesis and meta-analysis. The tool provides evidence-based mapping factors for 29 opioids through a research electronic data capture-based calculator and companion Web site (research-mme.wakehealth.edu). Development involved systematic evidence evaluation of literature from 1949 to March 2024, following PRISMA guidelines. From an initial screening of over 170,050 articles, we identified 24 studies providing evidence for conversion factors. The calculator incorporates 4 standardized time-window calculation methods aligned with current research approaches and includes traditional full agonists, partial agonists, and mixed-mechanism agents. Using modified GRADE methodology, we evaluated evidence quality for each conversion factor, documenting levels from high-quality randomized controlled trials to pharmacokinetic extrapolation. Our tool replicates most existing Centers for Disease Control and Prevention (CDC) conversion factors while expanding coverage to 7 additional opioids and 6 formulations not included in the 2022 CDC conversion table. The calculator features options to analyze results with or without buprenorphine, accommodating its emerging role in pain research. This standardized framework enables researchers to map opioid doses using consistent, evidence-based ratios and harmonize data collection across research networks. While the tool represents a significant advance in standardizing MME calculations for research, limitations in the underlying evidence base highlight the need for continued validation through clinical research.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/j.pain.0000000000003529 | DOI Listing |
Br J Anaesth
March 2025
Department of Anesthesiology and Pain Medicine, and the Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada; Department of Anesthesia, and the Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. Electronic address:
Background: Intrathecal morphine is the mainstay for post-Caesarean multimodal analgesia but is associated with important side-effects. Novel ultrasound-guided abdominal wall fascial plane blocks are proposed as intrathecal morphine alternatives, but evidence of effectiveness is conflicting. We compared the analgesic effects of fascial plane blocks with those of intrathecal morphine after Caesarean delivery.
View Article and Find Full Text PDFHernia
March 2025
Department of Surgery, Montefiore Medical Center, New York, NY, 10641, USA.
Background: Postoperative pain remains a common concern following ventral hernia repair (VHR), especially for open procedures. We aim to assess the effectiveness of the Transversus Abdominis Plane (TAP) block for the management of postoperative pain following VHR.
Methods: Cochrane, EMBASE, and PubMED, MEDLINE, and Web of Science were systematically searched for studies comprising adults undergoing VHR with preoperative TAP block, compared to placebo and epidural analgesia.
Objectives: Intractable headaches are a common occurrence in patients experiencing an aneurysmal subarachnoid hemorrhage (aSAH). Utilization of multimodal pain management regimens has become the standard of care for the treatment of acute and chronic pain. The primary objective of this study was to evaluate the use of a new multimodal pain regimen for headache in patients who have experienced aSAH.
View Article and Find Full Text PDFJ Rural Health
January 2025
VA Office of Rural Health (ORH), Veterans Rural Health Resource Center-Iowa City (VRHRC-IC), Iowa City VA Health Care System, Iowa City, Iowa, USA.
Purpose: To determine whether higher rates of opioid prescribing among rural Veterans in the Veterans Health Administration (VHA), previously observed through 2016, persisted through 2023.
Methods: National VHA administrative data were used to contrast opioid prescribing between urban and rural Veterans for annual veteran cohorts from 2016 through 2023. The primary prescribing metric was per capita volume expressed as morphine milligram equivalents (MME).
JTCVS Open
February 2025
Division of Cardiothoracic Transplantation, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex.
Background: Achieving adequate pain control after lung transplantation is an essential milestone in a patient's recovery. We compared postoperative opioid use, clinical outcomes, and respiratory function in lung transplant recipients treated with intercostal nerve cryoablation (INC) compared to those receiving standard pain management.
Methods: We reviewed all adult lung transplants performed at our center between January 2016 and December 2022.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!